Dual add-on therapy in type 2 diabetes poorly controlled with metoformin monotherapy: A randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metforminDiabetes Care - Rosenstock, J; Hansen, L; Zee, P (2015)
et al.